Recombinant IL-6R (Tocilizumab Biosimilar) anticorps
Aperçu rapide pour Recombinant IL-6R (Tocilizumab Biosimilar) anticorps (ABIN7487791)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Expression System
- Mammalian cells
-
Fonction
- Tocilizumab Biosimilar - Anti-IL-6R mAb
-
Attributs du produit
- Antibody Type: IgG1Kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 4°C for short term, -20°C for long term
-
-
- IL-6R (Tocilizumab Biosimilar)
-
Classe de substances
- Biosimilar
-
Sujet
-
Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. -
Numéro CAS
- 375823-41-9
Antigène
-